The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex
- 1 January 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 54 (10) , 687-694
- https://doi.org/10.1016/0024-3205(94)00552-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronideEuropean Journal of Pharmacology, 1991
- Oral morphine in cancer pain: influences on morphine and metabolite concentrationClinical Pharmacology & Therapeutics, 1990
- Morphine-3-glucuronide - a potent antagonist of morphine analgesiaLife Sciences, 1990
- Morphine-6-glucuronide: Analgesic effects and receptor binding profile in ratsLife Sciences, 1988
- High Doses of Spinal Morphine Produce a Nonopiate Receptormediated HyperesthesiaAnesthesiology, 1986
- High-Dose Morphine and Methadone in Cancer PatientsClinical Pharmacokinetics, 1986
- Intrathecal high dose morphine produces hyperalgesia in the ratBrain Research, 1981
- Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activityBrain Research, 1979
- Morphine metabolism in manClinical Pharmacology & Therapeutics, 1974
- Biochemical basis for analgesic activity of morphine-6-glucuronide—I: Penetration of morphine-6-glucuronide in the brain of ratsBiochemical Pharmacology, 1973